NCT01185353 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- Not reported
- Other-event reporting threshold
- 4%
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| 1 mg LY3009104 QD - Part A | 0 / 49 | 15 / 49 | Not reported / Not reported |
| 2 mg LY3009104 QD - Part A | 3 / 52 | 13 / 52 | Not reported / Not reported |
| 4 mg LY3009104 QD - Part A | 2 / 52 | 13 / 52 | Not reported / Not reported |
| 8 mg LY3009104 QD - Part A | 1 / 50 | 15 / 50 | Not reported / Not reported |
| Placebo QD - Part A | 3 / 98 | 18 / 98 | Not reported / Not reported |
| 2 mg LY3009104 BID Crossover- Part B | 2 / 63 | 15 / 63 | Not reported / Not reported |
| 4 mg LY3009104 QD Crossover- Part B | 1 / 63 | 10 / 63 | Not reported / Not reported |
| 2 mg LY3009104 QD - Part B | 0 / 51 | 12 / 51 | Not reported / Not reported |
| 4 mg LY3009104 QD - Part B | 0 / 50 | 10 / 50 | Not reported / Not reported |
| 8 mg LY3009104 QD - Part B | 3 / 49 | 18 / 49 | Not reported / Not reported |
| 4 mg LY3009104 QD - Part C | 16 / 108 | 35 / 108 | Not reported / Not reported |
| 4 to 8 mg LY3009104 QD Pre-Rescue - Part C | 1 / 61 | 7 / 61 | Not reported / Not reported |
| 4 to 8 mg LY3009104 QD Post-Rescue - Part C | 6 / 61 | 25 / 61 | Not reported / Not reported |
| 8 mg LY3009104 QD - Part C | 6 / 32 | 16 / 32 | Not reported / Not reported |
| 4 mg LY3009104 QD - Part D | 5 / 79 | 24 / 79 | Not reported / Not reported |
| 4 mg LY3009104 QD (4 to 8 mg Rescue)- Part D | 3 / 47 | 13 / 47 | Not reported / Not reported |
| 8/4 mg LY3009104 QD - Part D | 0 / 18 | 10 / 18 | Not reported / Not reported |
| Follow-Up | 2 / 159 | 5 / 159 | Not reported / Not reported |
Serious adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 1
- num At Risk
- 108
- num Events
- 1
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 98
- num Events
- 1
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Microcytic anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Normochromic normocytic anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 50
- num Events
- 1
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Pancytopenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Myocardial infarction
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 1
- num At Risk
- 108
- num Events
- 1
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Cataract
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Ulcerative keratitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 98
- num Events
- 1
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Coeliac disease
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Colitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Gastritis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Large intestinal obstruction
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Large intestinal stenosis
Other reported adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 52
- num Events
- 2
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 63
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 61
- num Events
- 1
- term
- Anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 50
- num Events
- 2
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Leukopenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 63
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Neutropenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Abdominal discomfort
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 51
- num Events
- 1
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Abdominal pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Acquired oesophageal web
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 49
- num Events
- 2
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 63
- num Events
- 2
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Dyspepsia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 98
- num Events
- 1
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 51
- num Events
- 1
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 50
- num Events
- 1
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 1
- num At Risk
- 108
- num Events
- 1
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Gastritis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Haemorrhoids
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Irritable bowel syndrome
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Oesophagitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 49
- num Events
- 2
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 63
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 50
- num Events
- 1
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Oedema peripheral
Complete source fields
- event Groups
- description
- Administered orally QD for 12 weeks in Part A. MTX was administered orally as background therapy.
- id
- EG000
- other Num Affected
- 15
- other Num At Risk
- 49
- serious Num Affected
- 0
- serious Num At Risk
- 49
- title
- 1 mg LY3009104 QD - Part A
- description
- Administered orally QD for 12 weeks in Part A. MTX was administered orally as background therapy.
- id
- EG001
- other Num Affected
- 13
- other Num At Risk
- 52
- serious Num Affected
- 3
- serious Num At Risk
- 52
- title
- 2 mg LY3009104 QD - Part A
- description
- Administered orally QD for 12 weeks in Pat A. MTX was administered orally as background therapy.
- id
- EG002
- other Num Affected
- 13
- other Num At Risk
- 52
- serious Num Affected
- 2
- serious Num At Risk
- 52
- title
- 4 mg LY3009104 QD - Part A
- description
- Administered orally QD for 12 weeks in Part A. MTX was administered orally as background therapy.
- id
- EG003
- other Num Affected
- 15
- other Num At Risk
- 50
- serious Num Affected
- 1
- serious Num At Risk
- 50
- title
- 8 mg LY3009104 QD - Part A
- description
- Placebo administered orally QD for 12 weeks in Part A. MTX was administered orally as background therapy.
- id
- EG004
- other Num Affected
- 18
- other Num At Risk
- 98
- serious Num Affected
- 3
- serious Num At Risk
- 98
- title
- Placebo QD - Part A
- description
- Participants who received Placebo or 1 mg LY3009104 in Part A were re-randomized at Week 12 to receive 2 mg LY3009104 BID in Part B. MTX was administered orally as background therapy.
- id
- EG005
- other Num Affected
- 15
- other Num At Risk
- 63
- serious Num Affected
- 2
- serious Num At Risk
- 63
- title
- 2 mg LY3009104 BID Crossover- Part B
- description
- Participants who received Placebo or 1 mg LY3009104 in Part A were re-randomized at Week 12 to receive 4 mg LY3009104 QD in Part B. MTX was administered orally as background therapy.
- id
- EG006
- other Num Affected
- 10
- other Num At Risk
- 63
- serious Num Affected
- 1
- serious Num At Risk
- 63
- title
- 4 mg LY3009104 QD Crossover- Part B
- description
- Participants who received 2 mg LY3009104 QD in Part A continued to receive 2 mg LY3009104 QD in Part B. MTX was administered orally as background therapy.
- id
- EG007
- other Num Affected
- 12
- other Num At Risk
- 51
- serious Num Affected
- 0
- serious Num At Risk
- 51
- title
- 2 mg LY3009104 QD - Part B
- description
- Participants who received 4 mg LY3009104 QD in Part A continued to receive 4 mg LY3009104 QD in Part B. MTX was administered orally as background therapy.
- id
- EG008
- other Num Affected
- 10
- other Num At Risk
- 50
- serious Num Affected
- 0
- serious Num At Risk
- 50
- title
- 4 mg LY3009104 QD - Part B
- description
- Participants who received 8 mg LY3009104 QD in Part A continued to receive 8 mg LY3009104 QD in Part B. MTX was administered orally as background therapy.
- id
- EG009
- other Num Affected
- 18
- other Num At Risk
- 49
- serious Num Affected
- 3
- serious Num At Risk
- 49
- title
- 8 mg LY3009104 QD - Part B
- description
- Participants who received 2 mg LY3009104 QD or BID in Part B were re-assigned at Week 24 to 4 mg LY3009104 QD in Part C. Participants who received 4 mg LY3009104 QD in Part B continued to receive 4 mg LY3009104 QD in Part C. MTX was administered orally as background therapy.
- id
- EG010
- other Num Affected
- 35
- other Num At Risk
- 108
- serious Num Affected
- 16
- serious Num At Risk
- 108
- title
- 4 mg LY3009104 QD - Part C
- description
- Participants who received 2 mg LY3009104 QD or BID in Part B were re-assigned at Week 24 to 4 mg LY3009104 QD in Part C. Participants who received 4 mg LY3009104 QD in Part B continued to receive 4 mg LY3009104 QD in Part C. During Part C, at Weeks 28 and 32, participants who met dose escalation criteria received 8 mg LY3009104 QD (rescue treatment) for the rest of the Part C. MTX was administered orally as background therapy. Adverse events were collected from Week 24 until predose of 8 mg LY3009104 QD.
- id
- EG011
- other Num Affected
- 7
- other Num At Risk
- 61
- serious Num Affected
- 1
- serious Num At Risk
- 61
- title
- 4 to 8 mg LY3009104 QD Pre-Rescue - Part C
- frequency Threshold
- 4
- other Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 52
- num Events
- 2
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 63
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 1
- num At Risk
- 61
- num Events
- 1
- term
- Anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 50
- num Events
- 2
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Leukopenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 63
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Neutropenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Abdominal discomfort
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 51
- num Events
- 1
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Abdominal pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Acquired oesophageal web
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 49
- num Events
- 2
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 1
- num At Risk
- 63
- num Events
- 2
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Dyspepsia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 98
- num Events
- 1
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 1
- num At Risk
- 51
- num Events
- 1
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 50
- num Events
- 1
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 1
- num At Risk
- 108
- num Events
- 1
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Gastritis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Haemorrhoids
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Irritable bowel syndrome
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Oesophagitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 49
- num Events
- 2
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 52
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 63
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 1
- num At Risk
- 50
- num Events
- 1
- group Id
- EG009
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Oedema peripheral
- serious Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 1
- num At Risk
- 108
- num Events
- 1
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 98
- num Events
- 1
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Microcytic anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Normochromic normocytic anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 50
- num Events
- 1
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Pancytopenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Myocardial infarction
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 1
- num At Risk
- 108
- num Events
- 1
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Cataract
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Ulcerative keratitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 98
- num Events
- 1
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Coeliac disease
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Colitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Gastritis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Large intestinal obstruction
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 16.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 52
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 98
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 51
- num Events
- 0
- group Id
- EG008
- num Affected
- 0
- num At Risk
- 50
- num Events
- 0
- group Id
- EG009
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG010
- num Affected
- 0
- num At Risk
- 108
- num Events
- 0
- group Id
- EG011
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- term
- Large intestinal stenosis
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle